Kuwait Sterile Injectables Cdmo Market Size & Outlook
Related Markets
Kuwait sterile injectables cdmo market highlights
- The Kuwait sterile injectables cdmo market generated a revenue of USD 8.2 million in 2024 and is expected to reach USD 11.9 million by 2030.
- The Kuwait market is expected to grow at a CAGR of 6.4% from 2025 to 2030.
- In terms of segment, large molecule was the largest revenue generating molecule type in 2024.
- Large Molecule is the most lucrative molecule type segment registering the fastest growth during the forecast period.
Sterile injectables cdmo market data book summary
| Market revenue in 2024 | USD 8.2 million |
| Market revenue in 2030 | USD 11.9 million |
| Growth rate | 6.4% (CAGR from 2025 to 2030) |
| Largest segment | Large molecule |
| Fastest growing segment | Large Molecule |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Small Molecule, Large Molecule |
| Key market players worldwide | Boehringer Ingelheim, Baxter International Inc, Vetter Pharma-Fertigung, Recipharm, Fresenius Kabi, Ajinomoto, PCI Pharma Services, IDT Biologika, Alcami, Fareva, Eurofins Scientific SE, Siegfried Holding AG |
Other key industry trends
- In terms of revenue, Kuwait accounted for 0.2% of the global sterile injectables cdmo market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa sterile injectables cdmo market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 27.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sterile Injectables CDMO Market Scope
Sterile Injectables CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Torbay Council | View profile | 1001-5000 | Torquay, Torbay, United Kingdom, Europe | https://www.torbay.gov.uk/ |
| Famar | View profile | 1001-5000 | Athens, Attiki, Greece, Europe | https://www.famar-group.com |
| Aenova Group | View profile | 5001-10000 | Greensboro, North Carolina, United States, North America | http://www.aenova-group.com |
| Fareva | View profile | 5001-10000 | Tournon-sur-rhône, Rhone-Alpes, France, Europe | http://www.fareva.com/ |
| Pfizer CentreOne | View profile | - | New York, New York, United States, North America | https://www.pfizercentreone.com |
| IDT Biologika | View profile | 1001-5000 | Dessau, Sachsen-Anhalt, Germany, Europe | https://idt-biologika.de/ |
| Ajinomoto | View profile | 10001+ | Tokyo, Tokyo, Japan, Asia | http://www.ajinomoto.com |
| Fresenius Kabi | View profile | 1001-5000 | Gurgaon, Haryana, India, Asia | https://www.fresenius-kabi-oncology.com/ |
| Unither Pharmaceuticals | View profile | 1001-5000 | Paris, Ile-de-France, France, Europe | https://www.unither-pharma.com/ |
| PCI Pharma Services | View profile | 1001-5000 | Philadelphia, Pennsylvania, United States, North America | http://www.pciservices.com |
| Alcami | View profile | 501-1000 | Wilmington, North Carolina, United States, North America | http://www.alcaminow.com |
| Vetter Pharma-Fertigung | View profile | 5001-10000 | Ravensburg, Baden-Wurttemberg, Germany, Europe | https://www.vetter-pharma.com/en |
| Recipharm | View profile | 1001-5000 | Jordbro, Stockholms Lan, Sweden, Europe | http://www.recipharm.com |
| Siegfried Holding AG | View profile | 4180 | Untere Bruehlstrasse 4, Zofingen, Switzerland, CH-4800 | https://www.siegfried.ch |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| Eurofins Scientific SE | View profile | 61798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | https://www.eurofins.com |
| Baxter International Inc | View profile | 60000 | One Baxter Parkway, Deerfield, IL, United States, 60015 | https://www.baxter.com |
Kuwait sterile injectables cdmo market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to sterile injectables cdmo market will help companies and investors design strategic landscapes.
Large molecule was the largest segment with a revenue share of 65.85% in 2024. Horizon Databook has segmented the Kuwait sterile injectables cdmo market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Kuwait sterile injectables cdmo market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Kuwait sterile injectables cdmo market databook
-
Our clientele includes a mix of sterile injectables cdmo market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait sterile injectables cdmo market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait sterile injectables cdmo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Kuwait sterile injectables cdmo market size, by molecule type, 2018-2030 (US$M)
Kuwait Sterile Injectables CDMO Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
